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Systems analyses have facilitated the characterization of metabolic networks of several organisms.
WehavereconstructedthemetabolicnetworkofLeishmaniamajor,apoorlycharacterizedorganism
thatcausescutaneousleishmaniasisinmammalianhosts.Thisnetworkreconstructionaccountsfor
560 genes, 1112 reactions, 1101 metabolites and 8 unique subcellular localizations. Using a systems-
based approach, we hypothesized a comprehensive set of lethal single and double gene deletions,
someofwhichwerevalidatedusingpublisheddatawithapproximately70%accuracy.Additionally,
we generated hypothetical annotations to dozens of previously uncharacterized genes in the
L.majorgenomeandproposedaminimalmediumforgrowth.Wefurtherdemonstratedtheutilityof
anetworkreconstructionwithtwoproof-of-conceptexamplesthatyieldedinsightintorobustnessof
the network in the presence of enzymatic inhibitors and delineation of promastigote/amastigote
stage-speciﬁc metabolism. This reconstruction and the associated network analyses of L. major is
the ﬁrst of its kind for a protozoan. It can serve as a tool for clarifying discrepancies between
data sources, generating hypotheses that can be experimentally validated and identifying ideal
therapeutic targets.
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Introduction
Computational modeling and systems analysis techniques can
facilitate the interrogation of biological systems on the genome
scale. Using available genomic, proteomic and metabolomic
data, models of biochemical networks with predictive capabil-
itiescanbeconstructed(Forst,2006).Computationalanalysisof
these reconstructed networks can give much insight into the
biological system and yield a set of hypotheses that can be
experimentally validated. For example, simulating gene knock-
outs and assessing robustness of particular enzyme-catalyzed
reactions enable evaluation of the efﬁcacy of potential drug
targets (Reed et al, 2006a; Jamshidi and Palsson, 2007).
The metabolic networks of several organisms, including
Escherichia coli, Helicobacter pylori, Saccharomyces cerevisiae
and Homo sapiens have been reconstructed, and the recon-
structions of many others are currently underway (Schilling
et al, 2002; Forster et al, 2003; Reed et al, 2003, 2006a;
Borodina and Nielsen, 2005; Duarte et al, 2007; Feist et al,
2007; Oberhardt et al, 2008). These network models have
facilitated the reconciliation of discrepancies between hetero-
geneous data sets (Reed et al, 2006a). Such systematic
compilation has enabled precise characterization of cellular
networks and aided in efforts to reﬁne genome annotation
(Feist et al, 2006; Reed et al, 2006a,b). The resultant in silico
models have predicted growth rates and gene essentiality
under different medium conditions and have characterizedthe
use of alternative carbon sources by particular organisms
(Schilling et al, 2002; Feist et al, 2006, 2007).
Here, we report the reconstruction of the metabolic network
of the parasite Leishmania major Friedlin, the causative agent
of cutaneous leishmaniasis. Closely related Leishmania spp.
cause diffuse cutaneous,mucocutaneous andvisceralforms of
the disease. Overall, leishmaniasis has an annual incidence
rate of two million cases and causes approximately 59000
deathsworldwideeachyear(Daviesetal,2003).Thevectorfor
this disease is a female phlebotomine sandﬂy (Lipoldova and
Demant, 2006). The morphological stages of Leishmania have
been previously described in detail (Molyneux and Killick-
Kendrick, 1987). Leishmania exist in ﬂagellated form known
as the promastigote within the sandﬂy gut. Upon contact with
the mammalian host, promastigotes enter macrophages and
transform into non-ﬂagellated amastigotes (see Figure S1 in
Supplementary Information I) (Lipoldova and Demant, 2006).
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representtheﬁrstconstraint-basedmodel fora protozoan. The
metabolic network reconstruction presented here accounts for
560 genes, 1112 reactions and 1101 metabolites. The recon-
struction is highly compartmentalized with eight unique
subcellular localizations accounted for in the model. We have
proposed novel single and double gene deletion predictions
resulting in a lethal phenotype. Additionally, we have
validated predictions of gene essentiality in the network with
published knockout studies from highly related Leishmania
and Trypanosoma species, and we demonstrated the utility of
the reconstruction in hypothesized reﬁnements of the L. major
genomeannotation. Other results include a novel prediction of
an in silico minimal medium to support growth, characteriza-
tion of network robustness and efﬁcacy of drug targets in the
presence of enzyme inhibitors, evaluation of morphological
stage-speciﬁc metabolism and examination of the iterative
design phase in model building. This type of systems analysis
not only provides a platform for data integration and
hypothesis generation to further scientiﬁc research in in-
fectious disease but also facilitates the identiﬁcation of
therapeutic drug targets against devastating tropical diseases
such as leishmaniasis.
Results
Properties of the metabolic network
The iAC560 metabolic network reconstruction (see section on
naming convention in Materials and methods) of L. major
accounts for 560 genes spanning the 36 chromosomes of the
genome, approximately 6.7% of all genes present in the
organism (see Figure 1A). The model included 1112 reactions
of which 1047 were metabolic and 65 were exchange. Of the
exchange reactions, 64 were input–output exchanges that
allowed extracellular metabolites in the medium to enter the
system orend products of metabolism to be excreted out of the
system. The remaining exchange reaction was the biomass
demand used as a drain for essential metabolites to character-
ize growth of the in silico system. iAC560 also accounted
for 1101 metabolites, a high number compared with other
metabolic reconstructions (Borodina and Nielsen, 2005; Reed
et al, 2006a). This was mostly due to the highly compartmen-
talized nature of the model; a total of eight unique compart-
ments were included in the model, namely the cytosol,
acidocalcisome,extracellularspace,mitochondria,glycosome,
endoplasmic reticulum, ﬂagellum and nucleus. Additionally,
108 literature references providing biochemical, physiological
and other validating information were used in reconstructing
the metabolic network of L. major.
The metabolites with the highest connectivity across
different compartments were identiﬁed (see Figure 1B). The
absolute value indicates the number of times a particular
metabolite occurred in any reaction of the stoichiometric
matrix (S-matrix). The relative value indicates percent
connectivity of the metabolite with respect to the entire
metabolic network. The hydrogen ion (or proton) was the
most connected metabolite in six out of eight compartments.
This result emphasizes the role of proton-dependent reactions
within the network. In the metabolic network reconstruction
of S. cerevisiae, another eukaryotic multi-compartment organ-
ism, the hydrogen ion was also the most highly connected
metabolite (Forster et al, 2003). Other highly connected
metabolites in L. major included ATP, ADP, H2O, phosphate
and diphosphate, which are known to participate in numerous
metabolic reactions.
The distribution of reactions across gene–non-gene associa-
tions, enzyme commission (EC) classiﬁcations, compartments
and metabolic processes was calculated (see Figures 1C–F).
The majority of metabolic reactions included in the recon-
struction were associated with genes (see Figure 1C). The
remainder comprised intracellular non-gene-associated reac-
tions, inter-compartment transport reactions and transporters
to the environment. Importantly, the intracellular non-gene-
associated reactions comprised only 6.5% of all the reactions
present in the model. This grouping contained reactions that
were spontaneous (those that proceeded without the presence
of enzymes) and reactions added for proper functioning of the
computational model. There were insufﬁcient gene annota-
tions or literature evidence for the latter. Also, many transport
reactions, which were added to provide access to enzymatic
reactions segregated in multiple locations within the cell, did
not have known gene associations. As shown in Figure 1D,
transferases, or enzymes that aid in transferring a functional
moietyfromonemetabolitetoanother,constitutedthegreatest
portion of enzymatic reactions in the model. For example,
hexokinase (EC: 2.7.1.1) transfers a phosphate from ATP to
glucose to yield glucose 6-phosphate and ADP. Interestingly,
the order of abundance of reactions grouped by EC classiﬁca-
tions in L. major was identical to that of S. cerevisiae,
emphasizing the high degree of conservation in metabolic
processes (Forster et al, 2003).
The cytosol and membrane-spanning groups accounted for
63.4% of all reactions (see Figure 1E). The membrane-
spanning group included inter-compartment transporters and
transporters to the environment in addition to certain
oxidative phosphorylation reactions that spanned the mito-
chondrial and acidocalcisomal (a vacuole-like compartment
ﬁrst discovered in trypanosomatids; Docampo et al, 2005)
membranes. The glycosome included approximately 6.0% of
reactions. The ﬁrst part of glycolysis is compartmentalized in
the glycosome, which also includes enzymatic reactions from
nucleotide and lipid metabolism among others (Hart and
Opperdoes, 1984; Opperdoes and Michels, 1993; Opperdoes
and Szikora, 2006). Not considering transport reactions, the
percentage of intracellular reactions participating in lipid
metabolism was the greatest when compared to reactions
across other metabolic subsystems (see Figure 1F). This was
partly due to the presence of two fatty acid synthesis
mechanisms present in trypanosomes: an endoplasmic
reticulum-based elongase pathway with fatty acyl groups
attached to coenzyme-A (CoA) and a mitochondrial type II
pathway with fatty acyl groups attached to acyl carrier protein
(Lee et al, 2007).
Single and double gene deletion predictions
Genes in iAC560 were ‘knocked-out’ and classiﬁed as lethal,
growth-reducing or having no effect. Figure 2 describes the
results of single and double gene deletion predictions, both
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1999; Schuster and Sullivan, 2002). Speciﬁcally, Figure 2A
illustrates that 12% of all single gene knockouts are lethal and
10% are growth reducing. For 2% of all gene knockouts,
growth is between 0 and 90%, and in 8% of the cases, growth
is between 90 and 100%. Figure 2B classiﬁes all lethal single
Figure 1 Network characteristics of iAC560. Fundamental characteristics of the iAC560 metabolic network are summarized. In (A) the total number of genes,
reactions, metabolites, subsystems (via the KEGG classiﬁcation scheme), compartments and literature references used in the model are listed. In (B), the most highly
connectedmetabolitesineverycompartmentofthe modelarepresented. Theabsolutevalueindicates thetotal numberoftimesaparticularmetaboliteisparticipating in
reactionswithinthe model. Therelative connectivity isequalto theabsolute connectivity divided bythe sum ofthe absolute connections ofall metabolitesinthe network.
(C–F) The iAC560 reactions grouped by gene–non-gene associations, enzyme commission (EC) classiﬁcations, compartments or subcellular localizations, and
metabolic processes, respectively. *ADP and ATP have equal connectivity in the ﬂagellum.
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are involved in. Approximately 83% of all lethal genes
belonged to three metabolic processes: lipid, carbohydrate or
amino-acid metabolism, highlighting how critical these are to
general function.
Of particular interestare genes that are lethal to L. major but
are not present in human. For example, LmjF05.0350, which
codes for trypanothione reductase, was lethal in silico. This
enzyme uses a cofactor N
1,N
8-bis (L-g-glutamyl-L-hemicysti-
nyl-glycyl) spermidine, otherwise known as trypanothione
(Fairlamb et al, 1985). This cofactor is only present in
Kinetoplastida (Krauth-Siegel et al, 2003), the class of
organisms to which Leishmania belongs. Additionally, trypa-
nothione reductase is an essential enzyme for the survival of
Leishmania spp. (Tovar et al, 1998; Krauth-Siegel et al, 2003).
Therefore, trypanothione metabolism is being studied as a
potential for therapeutic design and targeting (Benson et al,
1992; Dumas et al, 1997; Chan et al, 2002; Fairlamb, 2003;
Krauth-Siegeletal,2003).Modelpredictionsfortrypanothione
reductase were consistent with published literature. In
addition, tryparedoxin peroxidase (Alphey et al, 2000; Fair-
lamb, 2003) and fumarate reductase (Chen et al, 2001)
encoded by LmjF15.1040 and LmjF35.1180, respectively, both
lethal genes in silico, are also likely targets for antileishmanial
drugs as these enzymes are not present in mammalian cells.
Furthermore, the set of lethal gene knockouts include
LmjF31.2940 and LmjF21.0845, coding for squalene synthase
and hypoxanthine-guanine phosphoribosyltransferase, respec-
tively. There are inhibitors for both enzymes: 3-(biphenyl-4-
yl)-3-hydroxyquinuclidine (BPQ-OH) and ER27856 for
squalene synthase and 4-hydroxy-3,4-pyrazolopyrimidine
(allopurinol) for hypoxanthine-guanine phosphoribosyltrans-
ferase. These drugs have been experimentally tested against
trypanosomatids (Urbina et al, 2002; Urbina and Docampo,
2003; Braga et al, 2004). The squalene synthase inhibitors
affect the sterol biosynthesis pathway, taking advantage of the
trypanosomatid requirement for speciﬁc endogenous sterols
(e.g. ergosterol) (Urbina et al, 2002; Braga et al, 2004).
Allopurinol takes advantage of the inability of the trypanoso-
matid species to synthesize purines de novo (Urbina and
Docampo, 2003; Berriman et al, 2005). Each of the remaining
in silico lethal genes represents an individual hypothesis that
can be experimentally tested and validated.
In addition to single gene deletion predictions, all possible
doublegenedeletionswerealsosimulated(seeFigure2C).Out
of156520doubledeletions,19341werelethal.Another19285
double deletions were trivial lethal, i.e. at least one of the
genes involved was lethal in a single deletion. There were 56
non-trivial lethal double deletions, i.e. both genes involved
werenot lethal individuallyas single deletions, but were lethal
only in combination. An analysis of double gene deletion
effects on the metabolic network revealed that 57.6% of the
reactions affected participate in either lipid or carbohydrate
metabolism. The remaining 42.4% of the reactions are
involved in nucleotide, energy, amino acid, vitamin and
cofactor, secondary metabolite and xenobiotic metabolism.
These 56 double deletions are additional hypotheses that can
be experimentally validated and represent predictions of
genetic interactions and synthetic lethality that have proven
highly useful in published reports (Boone et al, 2007). The
large fraction of double deletions that were not lethal is
possibly indicative of the high degree of redundancy in the
network. See Supplementary Information II for a complete
listing of all non-trivial lethal double deletions.
Figure 2 Single and double gene deletion predictions. The results of in silico gene deletion predictions are summarized. (A) Single gene deletion predictions are
classiﬁed into four categories with respect to wild type: lethal (0%), growth reducing (>0% and o90%), growth reducing (>90% and o100%) and no effect (100%). For
each case, the percentage of growth is indicated in the parentheses. (B) The lethal single gene deletions grouped according to metabolic processes. (C) The total
numberoflethalsingleanddoublegenedeletions.Lethaldoublegenedeletionscanbeclassiﬁedastriviallethalornon-triviallethal.Triviallethalimpliesthatatleastone
of the genes involved is lethal in a single gene deletion. In non-trivial lethal double deletions, both genes involved are not lethal individually as single gene deletions but
are lethal in combination.
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The viability of selected simulations of gene knockouts was
compared with published data. Table I lists the complete set
of lethal and non-lethal knockouts obtained from literature
and the corresponding in silico predictions in four different
medium conditions, namely: minimal medium; minimal
medium and glucose; minimal medium, glucose and other
amino acids; and deﬁned medium (see Merlen et al, 1999;
Schuster and Sullivan, 2002). The rows colored gray, yellow
and white indicate agreement with literature, partial agree-
ment with literature and disagreement between iAC560
predictions and experimental data, respectively. The minimal
medium predictions had the greatest overall compliance with
72.4% agreement. Predictions in deﬁned medium had the
lowest overall compliance with 65.5% agreement. The other
two medium conditions had overall compliance of 69.0%.
Most often the experimental knockouts were done in varying
medium conditions. It is difﬁcult to characterize and replicate
in silico the exact environmental conditions that were used in
the experimental systems. This is a likely cause for the
discrepancy seen between the in silico and experimental
systems. Additionally, another cause for discrepancy can be
attributed to the fact that experimental data were obtained
fromrelatedLeishmaniaandTrypanosomaorganisms,andnot
entirely from L. major. In future iterations of the model,
discrepancies that exist in knockout data may be corrected by
addressing gene–protein-reaction (GPR) relationships, kinetic
constraints or gaps in the network.
Improving genome annotation through
reconstruction
The manual process of compiling and integrating data from
heterogeneoussourcessuchaspublicdatabasesandpublished
literature facilitates in clarifying discrepancies and providing
functional annotation to previously uncharacterized genes
(Feist et al, 2006). Table II indicates all of the annotation
reﬁnements proposedin the iAC560metabolic network. Out of
25 new annotations, 17 were previously characterized as
‘hypothetical proteins’ in public databases. The rest had either
an incorrect annotation, localization or EC classiﬁcation.
As an example of a hypothetical gene annotation reﬁne-
ment,considerLmjF23.1480,whichthisstudycharacterizesas
an‘alanineracemase.’ D-Alaninewasincludedasasubstratein
the experimentally deﬁned medium provided in Merlen et al
(1999); Schuster and Sullivan (2002). This was the ﬁrst
indication that the L. major genome coded for a racemase that
converted D-alanine into L-alanine, the latter isomer required
for protein synthesis (Panizzutti et al, 2006). However, there
were no L. major genes in KEGG (http://www.genome.jp/
kegg/) or GeneDB (http://www.genedb.org/) annotated as
‘alanine racemase.’ Moreover, two Trypanosoma cruzi genes
that coded for alanine racemasewere found. A BLAST (http://
www.expasy.org/tools/blast/) search using T. cruzi genes
resulted in very poor amino-acid sequence similarity against
L. major genes (E-value: 42.0). The existence of a cytosolic
alanine racemase in Leishmania amazonensis was previously
described (Panizzutti et al, 2006). Also, the presence of a
‘hypothetical protein’ in L. major with possible alanine
racemase activity was stated in Panizzutti et al (2006)
and a GenBank (http://www.ncbi.nlm.nih.gov/Genbank/
index.html) identiﬁcation number was provided, which was
associated with LmjF23.1480, annotated as a ‘hypothetical
protein, conserved’ in KEGG and GeneDB. However, there was
no localization or EC information provided in the databases. A
BLAST search was conducted, which showed strong amino-
acid sequence similarity with alanine racemase from several
organisms, including Ostreococcus tauri (E-value: 4e
 61),
Aspergillus fumigatus (E-value: 3e
 39), Aspergillus clavatus
(E-value: 3e
 39) and Schizosaccharomyces pombe (E-value:
1e
 37). EC information was obtained from the ExPASy
ENZYME database (http://ca.expasy.org/enzyme/). Hence,
the gene annotation for LmjF23.1480 was reﬁned as a
‘cytosolic alanine racemase’ with EC: 5.1.1.1.
As an example of an incorrect annotation in public
databases, the gene LmjF04.1160 was annotated as ‘fructose-
1,6-bisphosphatase, cytosolic’ in KEGG and GeneDB. This is a
gluconeogenic enzyme whose subcellular localization has
been characterized as the glycosome rather than the cytosol
(Naderer et al, 2006). Additionally, GeneDB stated that the
isoelectric point (pI) of the predicted peptide for LmjF04.1160
was 9.1. Enzymes in the glycosome are associated with highly
alkaline isoelectric points (Umasankar et al, 2005). The
existence of a peroxisomal-targeting signal 1 (PTS1) at the
extreme carboxyl terminus of the amino-acid sequence for
LmjF04.1160 was also discovered (Opperdoes and Szikora,
2006). The targeting signal was a three amino-acid peptide
consisting of serine, lysine and leucine (-SKL-), which is used
to characterize a glycosomal subcellular localization (Keller
et al, 1991; Opperdoes and Szikora, 2006). Hence, based on
literature, isoelectric point and targeting signal evidence, the
gene annotation for LmjF04.1160 was reﬁned as a ‘glycosomal
fructose-1,6-bisphosphatase.’ This type of model-driven dis-
covery would be impossible without a systematic model-
building approach that this reconstruction entails.
Reﬁnements of gene annotation typically surface whenever
a gap or dead end is identiﬁed in the in silico metabolic
network and there is no gene speciﬁed in the organism’s
genome to ﬁll in for that required metabolic function. Figure 3
illustrates the process employed in the construction of a GPR
when there is limited gene or EC information for a particular
reaction. A dead end occurs when a metabolite is either
consumed or produced only, hence violating the rule of mass
balance, the principal physiochemical constraint (Lee et al,
2006). Currently, there are 261 dead-end metabolites in the
L. major metabolic network. Consequently, there are 210
reactions with at least one participating dead-end metabolite
that will always have a ﬂux of zero. It is likely that in future
iterations of the reconstruction, more functional annotation
reﬁnements will surface as more gaps and dead ends are
resolved. See Supplementary Information III for all dead-end
metabolites belonging to various subcellular compartments
within the metabolic network.
In silico minimal medium prediction
An in silico minimal medium composed of arginine, cysteine,
histidine, isoleucine, leucine, lysine, methionine, phenylala-
nine, threonine, tryptophan, valine, hypoxanthine, phosphate
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Figure 4A delineates non-essential and essential substrates in
the deﬁned medium.
The list of essential amino acids contained in the in silico
minimal medium differed from those speciﬁed in the
experimentally deﬁned medium (see Merlen et al, 1999;
Schuster and Sullivan, 2002). Speciﬁcally, the experimental
medium listed three additional amino acids as being essential,
namely cystine, glutamine and tyrosine. Cystine, which is a
dimer of cysteines, was not included as a drain in biomass.
L. major has a gene for glutamine synthetase (LmjF06.0370),
which synthesizes glutamine from glutamate in the presence
of ATP and ammonia. Therefore, the model predicted that
glutamine was not essential for growth. In addition, L. major
has a gene for tyrosine aminotransferase (LmjF36.2360),
which can synthesize tyrosine from glutamate. ExPASy’s
ENZYME database noted that aspartate aminotransferase
(LmjF35.0820) can act on tyrosine as well.
Inaddition, bioinformatics analyses havebeen performedto
predict essential and non-essential amino acids in L. major
(Payne and Loomis, 2006). In prior work, if one or more genes
in an amino-acid pathway were missing in the organism, that
particular amino acid was characterized as being essential.
Through bioinformatics, cysteine was predicted as non-
essential and serine as an essential amino acid (Payne and
Loomis, 2006). Our minimal medium prediction indicated just
the inverse that cysteine was essential and serine was non-
essential. The model was still able to grow if serine and
hydrogen sulﬁde were allowed to enter the metabolic system
from the environment instead of cysteine, thus validating
the prediction of essential amino acids to that using solely
bioinformatics analyses (Payne and Loomis, 2006). There can
be several combinations of metabolites that can support
growth; however, the one particular combination of essential
medium with the fewest number of metabolites was chosen.
Hence, the reconstruction was used to predict essential
components of a deﬁned medium and aided in reconciling
discrepancies between published data sources (on essential
amino acids).
Since Leishmania spp. can growunderanaerobicconditions
(Darling et al, 1987), oxygen in the minimal medium was
replaced with tyrosine, uracil, ergosterol and zymosterol.
Additionally, 5-methylthioadenosine, an intermediate in sper-
midine synthesis, needed to be excreted out of the system for
the model to grow anaerobically. 5-Methylthioadenosine
is a by-product of the spermidine synthase reaction. An
enzymatic reaction downstream of spermidine synthase in the
methionine salvage cycle, namely 1,2-dihydroxy-3-keto-5-
methylthiopentene dioxygenase requires oxygen to produce
2-keto-4-methylthiobutyrate. Subsequently, tyrosine transa-
minase converts this metabolite and L-glutamate into L-
methionine and 2-oxoglutarate. For organisms that undergo
anaerobic respiration, the reaction that synthesizes 2-keto-4-
methylthiobutyrate has not been identiﬁed (Sekowska et al,
2004).
Contribution of minimal medium components to
biomass
The contribution of each component of minimal medium to
the generation of biomass precursors was computed (see
Figure 4B). After each minimal medium component was
eliminated, the red boxes denote the corresponding biomass
precursors that could not be generated, while the gray boxes
indicate the biomass precursors that were produced. For
example, if arginine was prevented from entering the meta-
bolic system, then arginine, putrescine and spermidine were
not produced. Likewise, if hypoxanthine was removed,
adenosine monophosphate (AMP), deoxyAMP (dAMP), deoxy-
guanosine monophosphate (dGMP) and GMP could not be
synthesized. Interestingly, this result validated a key point of
Figure 3 Construction of a gene–protein reaction (GPR) relationship. A
ﬂowchart highlighting the process of constructing a GPR based on the amount of
gene or EC information available for a particular reaction in public databases or
literature is illustrated.
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de novo (Berriman et al, 2005). In total, 9 out of 10 genes
codingforapathwaybeginningwith phosphoribosylpyropho-
sphate and ending in inosine monophosphate are not present
in trypanosomatids (Berriman et al, 2005). Therefore, a purine
source is required from the environment to fulﬁll purine
requirements in biomass. The minimal medium prediction
demonstrated that hypoxanthine, a purine derivative, was the
essentialpurinesource.Also,inFigure4B,adotted‘X’denotes
a biomass precursor that could not be generated when oxygen
and another component of minimal medium were restricted
from entering the metabolic system. Cysteine and oxygen had
Figure 4 Minimal medium prediction and effects of non-essential substrates in deﬁned medium on growth. (A) Minimal medium and non-essential substrates
indeﬁned mediumare delineated. Thedeﬁned mediumwasobtainedfromMerlenetal(1999);SchusterandSullivan(2002).(B)Theeffectsofinsilicominimalmedium
on production of biomass constituents are summarized. Gray- and red-colored boxes are indicative of particular biomass constituents that are and are not produced,
respectively, when the corresponding substrate in the minimal medium is prevented from entering the metabolic system. The dotted ‘X’ indicates biomass constituents
that cannot be produced when oxygen and another substrate in minimal medium are restricted from entering the metabolic system. (C) The effects of non-essential
substrates in deﬁned medium on growth rate are shown. The vertical bars represent normalized growth rate when each substrate is removed from the environment.
wSee Supplementary Information VII for all metabolite abbreviations.
zNon-essential substrates in deﬁned medium belonging to the ‘other’ category include a-D-glucose,
b-D-glucose, ascb, asn-L, asp-L, btn, ca2, chsterol, co2, fol, gln-L, glu-L, gly, gthrd, gua, h, h2o, inost, nac, ncam, nh3, nh4, pnto-R, pydx, pydxn, rib-D, so4, thym,
tyr-L and xan.
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and oxygen absent, metabolites such as S-adenosylhomocys-
teine, L-homocysteine, S-adenosylmethionine, O-succinyl-L-
homoserine and L-cystathionine among others were not
synthesized. These have important roles for the synthesis of
biomass constituents. For example, S-adenosylmethionine
plays a role in spermidine, zymosterol, ergosterol and
phosphatidylcholine synthesis, and is known to be one of
the most ubiquitous metabolites in metabolic networks
paralleling ATP (Reguera et al, 2007). The relationships
between minimal medium components and biomass consti-
tuents cannot be ascertained intuitively without these types of
network analyses.
Contribution of non-essential deﬁned medium
components to biomass
The effects of the non-essential deﬁned medium components
on growth rate were investigated. Each of the non-essential
substrates in deﬁned medium (see Figure 4A) was prevented
from entering the system and allowed only to be excreted
(ﬂux restricted to positive ﬂux space). Figure 4C depicts
the reduction in growth rate caused by removing each of the
non-essential substrates. Interestingly, the majority of the
substrates had absolutely no effect. Only 7 out of 36
metabolites had any effect on the growth rate. Preventing the
entry of deoxyribose into the metabolic system had the most
drastic effect of all, by causing a drop in growth rate by 16.8%.
The ﬂux through deoxyribokinase, which converts deoxyr-
ibose to 2-deoxy-D-ribose 5-phosphate with the help of ATP,
was reduced to zero. Consequently, the ﬂux through deoxy-
ribose-phosphate aldolase, which converts 2-deoxy-D-ribose
5-phosphate to acetaldehyde and glyceraldehyde 3-phosphate,
was reduced. In the reconstruction, acetaldehyde was trans-
portedintothemitochondriawhereitparticipatedinareaction
catalyzed by aldehyde dehydrogenase. The by-product of
aldehydedehydrogenasereaction,acetate,inturnwasusedfor
synthesisofacetyl-CoAviatheacetyl-CoAsynthetasereaction.
Acetyl-CoA, an important intermediate in the citrate cycle, is a
well-known precursor to fatty acid synthesis and several
biomass constituents (Wakil et al, 1964). Hence, due to
absence of deoxyribose in the medium, the ﬂux through the
acetyl-CoA synthetase reaction was reduced, which in turn
caused a reduction in growth rate.
F0F1-ATP synthase robustness analysis
The robustness of the metabolic network can be evaluated by
constrainingtheﬂuxofanyreactionfromitswild-typevalueto
zero and calculating the resultant effect on the growth rate. As
an example, oligomycin is an inhibitor of mitochondrial F0F1-
ATP synthase (Schnaufer et al, 2005). Therefore, the robust-
ness of the metabolic network in response to varying the ﬂux
of mitochondrial F0F1-ATP synthase-catalyzed reaction was
investigated. Figure 5 depicts the normalized growth rate
response to changing the ﬂux through mitochondrial F0F1-ATP
synthase reaction. At different ATP synthase ﬂux values, a
single optimization was run and growth rate (i.e. the ﬂux
through the biomass reaction) was measured. The graph
illustrates that growth rate is reduced to about 50% when the
ﬂux through ATP synthase is reduced to 8–9% of wild-type
ﬂux value. Reducing ATP synthase ﬂux to 40% of its wild-type
causes only a 3% change in growth rate. Robustness analysis
provides an optimal ﬂux value for a particular reaction that
corresponds to the optimal growth rate. This is a proof-of-
concept rather thanavalidation studyoftheinsilicometabolic
network. Particular enzymes with known inhibitors can be
targeted to help reduce the proliferation of Leishmania spp.
in mammalian hosts and subsequently slow the spread of
infection.
Amastigote or promastigote stage-speciﬁc
metabolism
Differential protein expression data from Leishmania infan-
tum suggested hexokinase was preferentially expressed in the
amastigote stage, while alcohol dehydrogenase, enolase and
ATP synthase were preferentially expressed in the promasti-
gote stage (Leifso et al, 2007). Figure 6 depicts the reactions
catalyzed by the differentially expressed enzymes. A red ‘X’
indicates that the ﬂux through a particular reaction was
reduced to 10% of its wild-type stage-independent value. The
value of 10% was arbitrarily chosen to emphasize that these
enzymes are not solely present in one stage over another, but
rather show higher abundance in a particular morphological
stage. Figure 7 illustrates the changes in normalized growth
rate as the ﬂuxes through the hexokinase, alcohol dehydro-
genase, enolase and ATP synthase reactions were reduced.
Sincehexokinasewasmorehighlyabundantintheamastigote,
knocking down ﬂux of hexokinase would partially represent a
promastigote metabolic network. Likewise, since alcohol
Figure 5 F0F1-ATP synthase robustness analysis. The normalized growth rate
corresponding to F0F1-ATP synthase ﬂux is plotted. The white circles indicate
single optimization simulations that are run at different ATP synthase ﬂux values
to measure ﬂux through biomass (growth rate).
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12 Molecular Systems Biology 2008 & 2008 EMBO and Nature Publishing GroupFigure 6 Reactions differentially expressed in amastigote or promastigote stages. The metabolic reactions that distinguish the morphological stages of L. major are
highlighted. These include reactions catalyzed by hexokinase, ATP synthase, alcohol dehydrogenase and enolase. The red ‘X’ indicates that the ﬂux through each
reaction is reduced to 10% of its wild-type stage-independent ﬂux value to characterize morphological stage-speciﬁc metabolism.
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dances in the promastigote, knocking down their ﬂuxes in
combination would imply an amastigote metabolic network.
As evidenced from the robustness analysis described above,
the mitochondrial F0F1-ATP synthase had the greatest impact
on the growth rate. The motivation for this analysis was not to
make predictions regarding growth rates in the two morpho-
logical forms of the parasite, but rather to demonstrate the
utility of integrating protein expression data with a genome-
scale metabolic network. Identifying pathways upregulated in
theamastigote,whichfacesadrasticallydifferentenvironment
inthemacrophageasopposedtoapromastigoteinthesandﬂy,
is critical when exploring novel therapeutic targets.
Model reﬁnement and iterative design
The step of model reﬁnement and iterative design (see
Figure S2 in Supplementary Information I) is an important
facet of the model-building process. According to the
literature, removing the function of adenosylmethionine
decarboxylase, spermidine synthase or ornithine decarboxy-
lase was lethal for Leishmania donovani (Jiang et al, 1999;
Roberts et al, 2001, 2002, 2004). Knocking out arginase was
lethal for Leishmania mexicana (Roberts et al, 2004). After the
ﬁrst iteration of the metabolic model, these four reaction
knockouts were non-lethal for the in silico growth of L. major
under deﬁned medium conditions. These four enzymes are
involved in polyamine (spermidine and putrescine) synthesis.
Additionally, it has been suggested that polyamine synthesis is
important for growth of Leishmania parasites (Bachrach et al,
1979a,b, 1981). Hence, spermidine and putrescine were
included in biomass to provide a drain for these essential
metabolites. Previous metabolic reconstructions for H. pylori
and Methanosarcina barkeri have also included polyamines as
part of biomass (Schilling et al, 2002; Feist et al, 2006).
After accounting for polyamines, a single optimization
simulation (maximization for biomass) was implemented.
However, there was no ﬂux through the biomass reaction, and
hence, no growth. This indicated that there existed a gap or a
dead end within the resulting network. Upon further investi-
gation,itwasconcludedthattherewasagapinthemethionine
salvage cycle, downstream of the spermidine synthase
reaction. Only the metabolite 5-methylthio-5-deoxy-D-ribose
1-phosphate was produced, violating the principal physio-
chemical constraint of mass balance. We subsequently added
four enzymatic reactions to the model, namely 5-methylthior-
ibose-1-phosphate isomerase, 5-methylthio-5-deoxy-D-ribu-
lose 1-phosphate dehydratase, enolase-phosphatase E-1 and
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase to
complete the methionine salvage cycle. KEGG and GeneDB
did not have functionally annotated genes for these enzymes.
LmjF28.1840, LmjF36.5910, LmjF20.0970 and LmjF34.4600,
previously uncharacterized genes, received new functional
annotation assignments (see Table II). LmjF36.4930 was
annotated in KEGG and GeneDB as ‘translation initiation
factor 2 subunit.’ However, a BLAST search showed strong
amino-acid sequence similarity with 5-methylthioribose-1-
phosphate isomerase from several organisms, including
S. pombe (E-value: 2e
 60), Syntrophomonas wolfei (E-value:
2e
 57), Pseudomonas syringae (E-value: 6e
 57), Pseudomonas
aeruginosa (E-value: 2e
 56) and Xylella fastidiosa (E-value:
2e
 56) (see Table II). Therefore, in iAC560, this gene was
annotated as ‘5-methylthioribose-1-phosphate isomerase.’
Whether this gene is involved in dual function requires
further investigation. After ﬁlling in the gaps in the
methionine salvage cycle and adding polyamines to biomass,
iAC560 predicted adenosylmethionine decarboxylase,
spermidine synthase, ornithine decarboxylase and arginase
as lethal knockouts in all in silico medium conditions
(see Table I).
Figure 7 Growth effects in amastigote and promastigote stages. The growth rate is assessed after accounting for the ﬂux through reactions catalyzed by differentially
expressed enzymes in amastigote and promastigote stages. Hexokinase is preferentially expressed in amastigotes, while ATP synthase, alcohol dehydrogenase and
enolase are preferentially expressed in promastigotes (Leifso et al, 2007). As a proof-of-concept, reducing the ﬂux through hexokinase represents a promastigote
metabolic network, and reducing the ﬂux through ATP synthase, alcohol dehydrogenase and enolase in combination implies an amastigote metabolic network. Vertical
bars indicate normalized growth rate. **The ﬂux through each reaction is reduced to 10% of its wild-type stage-independent ﬂux value.
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We present the ﬁrst constraint-based model for a protozoan
accounting for 560 genes, 1112 reactions, 1101 metabolites and
8 unique subcellular localizations. Among unicellular eukar-
yotes, Leishmania spp. are unique in their capability for
polycistronic transcription (Campbell et al, 2003), the pre-
sence of glycosome, acidocalcisome and ﬂagellar compart-
ments (Hart and Opperdoes, 1984; Opperdoes and Michels,
1993; de Souza, 2002; Docampo et al, 2005), their use of
trypanothione as an analog of glutathione (Fairlamb et al,
1985), the occurrence of novel fatty acid synthesis mechan-
isms (Lee et al, 2007) and the presence of kinetoplast DNA
(kDNA) network (Simpson and Da Silva, 1971; Stuart, 1983).
Using a systems-based approach, we identiﬁed 12% of
single gene knockouts in the network as lethal and 10% as
growth reducing, and proposed 56 non-trivial lethal double
deletions. Each one of these deletions constitutes a promising
drug target and an experimentally testable hypothesis. We
validated the metabolic network with experimental knockout
data from related Leishmania and Trypanosoma species.
In silico predictions in minimal medium had the best overall
compliance with experimental data (72.4%). Predictions in
minimal medium–glucose, minimal medium–glucose–other
amino acids and deﬁned medium had overall compliances of
69.0, 69.0 and 65.5%, respectively. Through the network
reconstruction and associated analyses, we demonstrated
systematic reﬁnement of genome annotation. A total of 17
out of 25 new annotation reﬁnements were proposed for
‘hypothetical proteins.’ The rest of the proposed annotations
wereforgenesthathadanincorrectannotation,localizationor
EC classiﬁcation.
In addition, we proposed a novel in silico minimal medium
that supports growth of L. major and evaluated growth
response to non-essential components in deﬁned medium.
The in silico medium consisted of arginine, cysteine, histidine,
isoleucine, leucine, lysine, methionine, phenylalanine, threo-
nine, tryptophan, valine, hypoxanthine, phosphate and oxy-
gen. The essential amino acids in our minimal medium
matched with those predicted by bioinformatics analyses with
one exception (Payne and Loomis, 2006). Permitting serine
and hydrogen sulﬁde to enter from the environment instead of
cysteine allowed the model to grow, and further validated our
prediction of essential amino acids with that in Payne and
Loomis (2006). However, we chose the minimal medium
composition based on the fewest number of metabolites
required for in silico growth.
The presence of hypoxanthine in the minimal medium
highlighted the fact that L. major is unable to synthesize
purines de novo (Berriman et al, 2005). If hypoxanthine is
removed, AMP, dAMP, dGMPand GMPcannot be synthesized.
Hypoxanthine, a purine derivative, fulﬁlls the purine source
requirement from the environment. Moreover, the majority of
non-essential components of deﬁned medium have no effect
on growth. Only 7 out of 36 metabolites had any effect, and
deoxyribosehadthemostdrasticeffectofall,causingadropin
growth rate by 16.8%. Preventing the entry of deoxyribose
affected synthesis of acetyl-CoA due to a reduction in ﬂux
through the acetyl-CoA synthetase reaction. Acetyl-CoA is an
important precursor to fatty acid synthesis and several
biomass constituents (Wakil et al, 1964). Finally, we provided
two proof-of-concept examples yielding insight into the utility
of network reconstruction; the robustness of the metabolic
network was evaluated by varying the ﬂux through F0F1-ATP
synthase reaction, and pathways differentially upregulated in
the morphological stages of the parasite were identiﬁed by the
use of protein expression data.
A comprehensive metabolic model such as iAC560 is an
ideal forum for continual integration and interpretation of
high-throughput data. Systems analysis of L. major is
particularly challenging because, unlike organisms like E. coli
and S. cerevisiae, L. major is not as well-characterized
experimentally. As more information on L. major becomes
available, the model will be reﬁned to better match experi-
mentalvalidatingdata.Asanexampleofthemodelreﬁnement
process, we identiﬁed four gaps in the methionine salvage
cycle and provided functional annotation to previously
uncharacterized genes. Consequently, we improved our
compliance of knockout predictions with experimental data
from 51.7 to 65.5% agreement under deﬁned medium
conditions.
Limitations of the model include poor gene associations for
inter-compartment transport reactions and transporters to the
environment.Mostof themetabolitesin iAC560that needed to
be transported across membranes were allowed to do so via
passive diffusion. It was previously published that metabolites
and coenzymes cannot permeate through the glycosomal
membrane (Bakker et al, 2000). A publicly accessible
membrane transport database, TransportDB (http://
www.membranetransport.org/), has gene listings for trans-
porters in L. major that will need to be investigated. The
metabolic network also did not account for kDNA. L. major
maxicircle kDNA plays an important role in energy metabo-
lism, encoding for subunits of NADH-ubiquinone oxidoreduc-
tase, for example (Akopyants et al, 2004).
Comparing the metabolic network of L. major with that of
humans can aid in identifying unique features of trypanoso-
matid metabolism. Focusing on metabolic causes of patho-
genicity and virulence will lead to discovery of unique
therapeutic targets dissimilar from human metabolism.
Ultimately, the genome-scale metabolic reconstruction of
L. major presented here provides a framework for the
interrogation of human pathogens and a platform for integra-
tion of high-throughput data and generation of experimental
hypotheses. These types of novel network analyses may be
relevant to treating infectious diseases, particularly when
diseases like leishmaniasis are considered emerging and
uncontrolled, necessitating improvements in therapeutics
and treatment strategies (Remme et al, 2002).
Materials and methods
Metabolic network reconstruction
The process of reconstructing the metabolic network of an organism
has been thoroughly described in the literature (Edwards and Palsson,
2000; Schilling et al, 2002; Forster et al, 2003; Reed et al, 2003, 2006a;
BorodinaandNielsen,2005;Franckeetal,2005;Feistetal,2006,2007;
Duarte et al, 2007; Jamshidi and Palsson, 2007; Kim et al, 2007).
The basis of a metabolic reconstruction is the formulation of
GPR relationships and organization of reactions into a S-matrix for
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with rows of metabolites and columns of reactions, is comprised of
stoichiometric coefﬁcients corresponding to the chemical transforma-
tions in the network. For example, a reaction where 1mol of ‘A’ yields
1mol of ‘B’ may be represented as a single column in the S-matrix,
with the rowcorresponding to ‘A’ having a ‘ 1’ denoting consumption
of1molof‘A’andtherowcorrespondingto‘B’havinga‘þ1’denoting
production of 1mol of ‘B.’
Using a variety of data sources such as gene and protein databases,
biochemistry textbooks and published literature, information relating
to gene locus, enzyme biochemistry, reaction stoichiometry and
subcellularlocalizationwascompiled(seeFigureS2inSupplementary
Information I). Further, rules on reaction reversibility and promasti-
gote/amastigote protein expression data were used to delineate the
lower and upper bounds on reaction ﬂuxes for every reaction in the
S-matrix. With the ability of trypanosomes, unlike other eukaryotic
organisms, to perform polycistronic transcription (Campbell et al,
2003), one transcript can potentially code for multiple proteins.
However, a simplifying assumption was made at the start of the
reconstruction process to allow one gene to code for a single protein.
The single protein, however, was allowed to catalyze multiple
reactions in different subcellular compartments. Two or more proteins
arising from independent genes that catalyze the same reaction (e.g.
isozymes) were characterized with an ‘OR’ relationship. Two or more
proteins that are needed to work in conjunction for a reaction to occur
(e.g. as subunits in a protein complex) were characterized with an
‘AND’ relationship (Reed et al, 2006a; Duarte et al, 2007).
Published literature was explored extensively for assigning sub-
cellular localizations to reactions. In cases where literature evidence
waslimited,thepresenceofsignalingpeptideswastakenintoaccount.
SeveralmetabolicgenescontainingaPTSwerelistedinOpperdoesand
Szikora (2006), and this list was used for locating particular reactions
to the glycosome, a unique trypanosomatid peroxisome-like organelle.
In some cases, an isoelectric point (pI) of above 8.4 was also used to
place reactions into the glycosome (Umasankar et al, 2005). In
addition, the PSORT prediction tool (http://psort.nibb.ac.jp/) was
used to locate targeting signals for compartments other than the
glycosome. When no literature evidence or presence of targeting
signals was available, the default subcellular compartment was the
cytosol.
Reactions in the metabolic network were classiﬁed as gene
associated or non-gene associated. Those reactions that occurred
spontaneouslywithoutthepresenceofanenzymeandinsilico‘model’
reactions comprised the non-gene-associated category. Several sub-
cellular transport reactions and transporters to the extracellular
environment were added to the model as in silico ‘model’ reactions
due to lack of gene annotations and literature evidence. Various types
of network analyses are possible following a metabolic network
reconstruction. As illustrated in Figure S2 in Supplementary Informa-
tion I, the iterative model-building process is vital for subsequent
modelreﬁnement.See SupplementaryInformationIVfor thecomplete
metabolic reconstruction in Microsoft Excel format, Supplementary
Information V for complete metabolic reconstruction in SBML format,
Supplementary Information VI for a comprehensive reaction map and
Supplementary Information VII for all metabolite abbreviations.
Naming convention
The L. major metabolic reconstruction was named following the in
silico labeling convention ﬁrst introduced in Reed et al (2003). The
computational model was named ‘iAC560,’ where ‘i’ denotes ‘in silico,’
‘AC’ indicates the initials of the ﬁrst author and ‘560’ represents the
number of L. major genes accounted for in the model.
Fatty acid composition
The fatty acid composition for L. major was obtained from Vessal et al
(1974). Chain lengths with less than 2% prevalence were not taken
into account and the percentages of the remaining fatty acids were
normalized. Subsequently, based on the percentages of individual
chain lengths, an average fatty acid chain length was derived. It was
assumed that all metabolites with fatty acyl side chains in Leishmania
had equivalent chain lengths. See Supplementary Information VIII for
the average fatty acid composition and the molecular formulas of all
metabolites in the model with fatty acyl side chains.
Biomass calculations
The purpose of the biomass equation is to provide a drain of essential
metabolites that are needed to support growth of the metabolic system
(Varma and Palsson, 1993; Edwards and Palsson, 2000). The equation
isan approximationas thecompositionislikely tovary underdifferent
physiological conditions (Varma and Palsson, 1993). However, it has
been shown that perturbations in the coefﬁcients of the metabolites
present in biomass do not affect overall biomass yield signiﬁcantly
(Varma and Palsson, 1993, 1994). Additionally, model predictions
have been shown to be insensitive to various factors including ATP
maintenance and biomass scaling (Varma and Palsson, 1995). Due to
the scarcity of data on cellular composition for L. major, data from
related Leishmania species and other protozoans (e.g. Tetrahymena)
was used. Therefore, the biomass equation used is only an estimate
and mainly serves to provide a demand for essential metabolites. See
Supplementary Information I for detailed explanation on the deriva-
tion of the biomass equation used in the computational analysis.
Flux balance analysis
Flux balance analysis (FBA) has been extensively used to interrogate
metabolic networks (Edwards and Palsson, 2000; Schilling et al, 2002;
Forster et al, 2003; Reed et al, 2003; Feist et al, 2006, 2007; Duarte et al,
2007; Jamshidi and Palsson, 2007; Kim et al, 2007). FBA is used to
generate a set of steady-state ﬂuxes for all the reactions in the
biochemicalnetworkupontheoptimizationofan objectiveunderaset
of constraints (see Kauffman et al (2003); Lee et al (2006) for more
detailed review of FBA). Constraints can be categorized into four
different types: physicochemical, topological, thermodynamic and
environmental (Kauffman et al, 2003; Lee et al, 2006). The principal
physicochemical constraint used in FBA is conservation of mass.
Topological constraints include restrictions placed on metabolites due
to subcellular compartmentalization, thermodynamic constraints are
appliedbydeﬁningeffective irreversibilityof a particular reaction, and
environmentalconstraintsaredeﬁnedbythemediuminwhichthecell
is cultivated (Lee et al, 2006).
The change in concentration of a metabolite in the network can be
represented in terms of the ﬂuxes through the reactions in which the
metabolite is participating.
dC
dt
¼ Sv ð1Þ
In equation (1),‘C’ is a vector of concentrations of metabolites,‘t’i s
time,‘S’ is the S-matrix with m rows of metabolites and n columns of
reactions and ‘v’ is a vector of ﬂuxes through the corresponding
reactions. At steady state, the change in concentration of any
metabolite over time throughout the cellular network is zero. The
steady-state assumption, frequently applied in the analysis of
metabolic networks, is reasonable for a metabolic network as
individual reactions are fast in comparison to changes in the overall
cellular objective, such as maximization of growth rate (Lee et al,
2006).
Therefore,
dC
dt
¼ 0 ð2Þ
And,
Sv ¼ 0 ð3Þ
Because of the under-determinednatureof the system (i.e. the number
of equations is less than the number of unknown ﬂuxes), a linear
programming(LP)formulationwasusedtogenerateaﬂuxdistribution
for the entire network. Typical objective functions include maximizing
for biomass production, maximizing or minimizing for ATP or
maximizing for certain by-products of the metabolic system (Lee
et al, 2006). In this study, the biomass equation was the objective
function for simulating growth of L. major. In addition to conservation
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promastigote/amastigote protein expression data, various medium
conditions and prevalence of transport reactions across cellular
compartments. All intracellular reversible reactions were allowed to
traverse the entire ﬂux space from  N to þN (mmol/gDW/h).
Fluxes on irreversible intracellular reactions (mmol/gDW/h) and the
biomass demand (h
 1) were restricted to the positive ﬂux space from
0t oþN. The ﬂuxes on substrates (mmol/h) present in the
experimentally deﬁned medium (see Merlen et al (1999); Schuster
and Sullivan (2002)) were constrained between  100 and þ100, i.e.
these substrates were free to enter or leave the system. Reactions that
allowed entry of metabolites not present in the deﬁned medium had
their ﬂuxes constrained from 0 to 100, i.e. these metabolites were only
allowed to be excreted out of the system. For minimal medium
simulations, the ﬂuxes on substrates present in minimal mediumwere
constrainedbetween Nto þNandremainingsubstrateﬂuxeswere
constrained to the positive ﬂux space (biomass ﬂux was constrained
toþ100). All LP simulations were carried out in Simphenyt
(Genomatica, San Diego, CA).
Single and double gene deletion predictions
Gene deletion predictions allowed for identiﬁcation of genes that were
lethal for growth of L. major. Each of the 560 genes in the metabolic
network was ‘knocked out’ and grouped into one of the following
categories with respect to wild type: lethal (0%), growth reducing
(40% and o90%), growth reducing (490% and o100%) and no
effect (100%). For each case, the percentage of growth is indicated in
the parenthesis. All possible double deletions were also simulated and
classiﬁedastriviallethalornon-triviallethal.Intriviallethaldeletions,
at least one of the genes involved is lethal in a single deletion, and in
non-trivial lethal deletions, both genes involved are not lethal
individually as single deletions but are lethal only in combination.
Single and double gene deletion predictions were performed under
deﬁned medium conditions (see Merlen et al (1999); Schuster and
Sullivan (2002)). The substrates included in deﬁned mediumare listed
in Figure 4A.
Validation of reaction knockout predictions
Experimental data on gene essentiality in L. major were not readily
available, and RNA interference has not been effectivelydemonstrated
in Leishmania spp. (Beverley, 2003; Opperdoes and Michels, 2008).
Therefore,geneknockoutdatawereobtainedfrompublishedliterature
for related Leishmania and Trypanosoma species. Data for six
knockouts were obtained from TrypanoFAN (http://trypanofan.path.
cam.ac.uk/trypanofan/main/), the Trypanosoma brucei functional
genomics project. A reaction knockout strategy (as opposed to
individual gene knockouts) was pursued to completely remove
function encoded by particular genes obtained from literature. The
in silico reaction knockouts were carried out under four different
medium conditions: (a) minimal medium, (b) minimal medium and
glucose, (c) minimal medium, glucose and other amino acids and
(d) deﬁned medium (see Merlen et al (1999); Schuster and Sullivan
(2002)). The model results were compared with experimental knock-
out studies.
In silico minimal medium prediction
The completely deﬁned medium for the continuous cultivation and
growth of Leishmania promastigotes has been experimentally
characterized (Merlen et al, 1999; Schuster and Sullivan, 2002). With
the exception of a few vitamins and salts, the majority of the
metabolites in the experimentally deﬁned medium were accounted for
in the L. major metabolic network reconstruction. To predict an in
silico minimal mediumforgrowth,each of the extracellularmetabolite
ﬂuxes wasprevented fromentering the metabolic system. Thisyielded
a combination of essential metabolites necessary to support growth.
Constraining the ﬂuxof anyone of these essential metabolites resulted
in no growth (the ﬂux of biomass was 0h
 1).
Characterizing stage-speciﬁc metabolism
L. major exists as an amastigote within macrophages in the human
host. Therefore, identifying speciﬁc pathways of L. major metabolism
that are differentially upregulated in amastigotes as opposed to
promastigotes is necessary. With the help of mRNA or protein
expression data, morphological stage-speciﬁc metabolic networks
can be characterized. The mRNA expression may not directly
correspond to protein expression in Leishmania spp., and obtaining
protein expression data from L. major lesion-derived amastigotes can
be challenging as they are difﬁcult to culture in vitro (Leifso et al,
2007). Therefore, as a proof-of-concept, information on differential
protein expression from L. infantum (a related Leishmania spp.) was
integrated with the in silico L. major metabolic network. According to
the thresholds set in Leifso et al (2007), hexokinase was preferentially
expressed in the amastigote stage, while alcohol dehydrogenase,
enolase and ATP synthase were preferentially expressed in the
promastigote stage. The ﬂuxes through each of these reactions were
reduced to 10% of their wild-type stage-independent values and the
effects on growth rate were observed.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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